Cannabis Law Report

JANUARY 14, 2022

Right-to-try aims to allow patients who have been diagnosed with life-threatening diseases or conditions who have tried all approved treatment options and who are unable to participate in a clinical trial to access certain unapproved treatments. Right-to-try permits those patients to have access to investigational drugs.

Treatment 52

Treatment Access Clinical Trials Patients 52

NORML

APRIL 30, 2020

.” This finding is hardly a surprise, as cannabis is well-established to mitigate pain in clinical models, particularly in patients with neuropathy. ” Among pain patients enrolled in medical cannabis access programs, most subjects report eventually decreasing or even eliminating their use of opiates.

Chronic Pain 343

Chronic Pain Clinical Trials Data Patients 343

MMJ Recs

MAY 9, 2024

As the medical marijuana field continues to evolve, the potential benefits for veterans have increasingly come to the forefront. For veterans considering medical marijuana as a treatment option, it’s essential to approach its usage with careful consideration and understanding.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Veriheal

DECEMBER 21, 2022

President Joe Biden has officially signed a marijuana research bill into law. 8454, the “Medical Marijuana and Cannabidiol Research Expansion Act,” has been passed. attorney general 60 days to either approve a given application or request supplemental information from the marijuana research applicant. The law gives the U.S.

Clinical Trials 98

Clinical Trials Marijuana Decriminalization History 98

NORML

JANUARY 31, 2019

. “Federal lawmakers must stop discriminating against veterans with regard to matters of marijuana and health,” said NORML Political Director Justin Strekal. Additional information is available from the NORML fact-sheet, “Marijuana and Veterans Issues,” here.

Clinical Trials 190

Clinical Trials Chronic Pain Data Treatment 190

Cannabis Law Report

MARCH 30, 2022

The action represents one of the very few occasions that members of the Senate have ever advanced a marijuana-related reform bill. Under this proposal, the AG is also provided with the ability to authorize increases in the total number of federally approved marijuana cultivators. BILLS-117s253es.

Legislation 95

Legislation Clinical Trials DEA Access 95

NORML

MARCH 1, 2019

The American Psychological Association (APA) is urging US Attorney General William Barr to review more than two-dozen pending applications for federal marijuana grow licenses. ” The APA represents nearly 120,000 researchers and clinicians. .” ” The APA represents nearly 120,000 researchers and clinicians.

DEA 164

DEA Research and Development Clinical Trials Marijuana 164

NewsMunchies

DECEMBER 13, 2021

In the largest clinical trial to date, a new study conducted by the UK-based pharmaceutical company Compass Pathways shows that psilocybin or “magic” mushrooms can safely relieve depression. The trial included 233 patients from 10 countries in North America and Europe. In 2019, Denver became the first city in the U.S.

Clinical Trials 95

Clinical Trials Therapy Decriminalization Patients 95

CannaMD

APRIL 23, 2020

And while there’s currently no known cure for Parkinson’s disease, a marijuana-based medication created by GB Sciences has demonstrated promising results — catching the eye of both the scientific community and medical cannabis patients alike. Parkinson’s Disease: Marijuana Studies. You may be eligible for medical marijuana!

Clinical Trials 116

Clinical Trials Research and Development Marijuana Treatment 116

Veriheal

MARCH 23, 2023

The people of Japan, a country renowned for its sushi cuisine scene, iconic Mount Fuji, and eye-catching cherry blossom trees, may soon have access to legal medicinal marijuana for intractable diseases. 124’—the use and application of medicines manufactured from “marijuana” to any person are currently prohibited.

Legalization 66

Legalization Marijuana Clinical Trials Seed-To-Sale 66

MMJ Recs

DECEMBER 17, 2023

The Texas Compassionate Use Program (TCUP) represents the Lone Star State’s cautious foray into the realm of medical marijuana. Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals.

Law 52

Law Dispensary Clinical Trials Programs 52

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

MMJ Recs

NOVEMBER 20, 2023

In recent years, the medical community and the public have shown a growing interest in the therapeutic potential of medical marijuana. This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Project CBD

FEBRUARY 28, 2023

THC is considered “marijuana” or “cannabis.” 5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Accessed July 25, 2021.

CBD 144

CBD Seed-To-Sale Food Access 144

NORML

JANUARY 4, 2019

Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution. The measures would regulate the use, possession, and retail sale of marijuana by adults.

Legislation 126

Legislation Clinical Trials Research and Development Access 126

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. 2022 Active FDA Clinical Trials and State-Regulated Systems. Active FDA Regulated Clinical Trials*. On March 5, 2019, the U.S. Schedule I.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

OCTOBER 20, 2021

Bank of America (BoA) is reportedly terminating its banking relationship with Scottsdale Research Institute (SRI), a DEA-registered facility that carries out important marijuana research. The quality of this cannabis had been criticised by a number of researchers, including Dr. Sisley.

Banking 52

Banking Clinical Trials DEA History 52

MMJ Recs

DECEMBER 22, 2023

Medical marijuana, once a controversial and stigmatized topic, has undergone a remarkable transformation in the eyes of the American public. Changing Public Opinion on Medical Marijuana in the United States In recent decades, the public’s stance on medical marijuana has shifted from skepticism to acceptance.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

JUNE 24, 2022

Marijuana Moment reports. The leader of the New Jersey Senate filed a bill on Thursday that would legalize the possession, home cultivation and gifting of psilocybin mushrooms for adults 21 and older—with provisions that give adults even more freedoms for the psychedelic than are afforded under the state’s current marijuana laws.

Clinical Trials 52

Clinical Trials Legalization Research and Development Therapy 52

LifeCannMD

FEBRUARY 1, 2022

As a result, people are starting to explore medical marijuana for obsessive-compulsive disorder instead. In this article, you’ll learn why and how medical marijuana is effective for treating OCD. Prescription Medicines Vs. Marijuana and OCD. There are two traditional ways to address OCD besides just medical marijuana.

Marijuana 98

Marijuana Clinical Trials Patients Therapy 98

The Cannigma

JUNE 14, 2021

All that is about to change, thanks to a change at the DEA , which cultivators and industry experts say will be monumental for cannabis research, medical marijuana patients, and potentially the broader legal status of the plant itself. “We Junk’ cannabis ‘ill-suited for clinical trials’.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Canna Law Blog

NOVEMBER 6, 2021

Despite overwhelming evidence that psilocybin is misclassified, this barrier restricts research, stifles competition and innovation, and inhibits access. But only if it is made affordable and accessible. Instead, qualifying evidence may come from adequate and well-controlled clinical trials. For two decades, U.S.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Otherside Farms

JANUARY 25, 2019

A medical marijuana patient in Los Angeles with inoperable liver cancer has been removed from Cedars-Sinai Medical Center’s transplant list after testing positive for marijuana. Sixty-three-year-old medical marijuana patient Norman B. The letter also urges Cedars-Sinai to change its transplant eligibility policy.

Patients 76

Patients Clinical Trials Marijuana Policy 76

Cannabis Law Report

APRIL 21, 2022

The availability of larger quantities of cGMP-compliant MDMA will facilitate ongoing clinical trials and provide for future therapeutic use following anticipated regulatory approvals. Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public .

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Veriheal

MAY 3, 2022

A recent study , funded by the National Institute on Drug Abuse (NIDA) and published in JAMA Network Open , reported a correlation between obtaining a medical marijuana (MMJ) card and developing CUD. a necessary question to address as medical marijuana becomes more accessible. Clinical Trial Sample Size.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

Cannabis Law Report

JANUARY 26, 2022

MAPS Public Benefit Corporation will coordinate trial design with Medicines and Healthcare products Regulatory Agency to create a road map for early patient access in the UK. No drug is without risks, so clinical trials have included careful investigation of possible adverse effects.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

SpeedWeed

SEPTEMBER 17, 2021

Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. The millions of people afflicted with PTSD may soon have access to MDMA therapy, and we believe the millions suffering from TBI may experience similar relief in the future.”.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

NORML

OCTOBER 21, 2019

The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials. Since 1968, the agency has only licensed the University of Mississippi to engage in the growing of cannabis for FDA-approved clinical research. .”

DEA 104

DEA Cultivation Clinical Trials Policy 104

CannaMD

NOVEMBER 6, 2019

Marijuana has long been used for pain in medical traditions around the world. Today, both patient experience and modern scientific research support claims of medical marijuana’s effectiveness for pain management. It is also known that marijuana targets the body’s pain receptors in ways similar to synthetic opioids.

Marijuana 87

Marijuana Patients Clinical Trials Data 87

NewsMunchies

NOVEMBER 12, 2021

In clinical trials, psilocybin (the psychoactive substance in mushrooms) has shown tremendous promise in treating severe depression, post-traumatic stress disorder, and other mental illnesses. Additional clinical trials underway in the U.S. and Europe are aimed at winning regulatory approval. Rate this blog post.

Clinical Trials 90

Clinical Trials Therapy Decriminalization DEA 90

Canna Law Blog

NOVEMBER 27, 2021

DMT, like its sister psychedelics (LSD, MDMA, psilocybin … and even marijuana), is a Schedule I controlled substance. In fact, Small Pharma has been conducting trials as reported by the BBC and expanded its clinical trial this past summer. DMT, or N, N-dimethyltryptamine is a powerful psychedelic.

Therapy 87

Therapy Clinical Trials DEA Microdosing 87

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? During my tenure, I have found the medical marijuana educational gap to be one of the most significant educational gaps that impacts a very broad range of healthcare providers. million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

The Joint Blog

JUNE 2, 2020

The study, titled Pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial , was first published by NORML. The post Study: Marijuana Inhaler Safe and Effective for Treating Chronic Pain appeared first on TheJointBlog.

Chronic Pain 58

Chronic Pain Clinical Trials Safety Marijuana 58

Veriheal

NOVEMBER 9, 2021

House of Representatives approved a bill on Friday that will allow researchers to study commercial cannabis sold in state-legal dispensaries instead of having to depend on government-grown cannabis, Marijuana Moment reports. or less THC.

Clinical Trials 52

Clinical Trials Research and Development Chronic Pain Dispensary 52

The Joint Blog

FEBRUARY 11, 2022

However, it warrants further examination and exploration by science in the form of clinical trials, which is what many in the scientific community are calling for. This includes clinical trials on humans. The hope is that clinical trials will begin soon to learn more about the benefits of CBD for a virus and beyond.

Clinical Trials 49

Clinical Trials CBD Conditions Data 49

NORML

SEPTEMBER 20, 2019

We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. Dr. Sisley isn’t just trying to study medical marijuana; she’s trying to get cannabis flowers approved by the FDA as tried-and-true medicine. Dr. Sue Sisley.

DEA 230

DEA Research and Development Clinical Trials Patients 230

NORML

JANUARY 18, 2019

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. At the state level, patients in Ohio and Oklahoma now have access to medical cannabis, as sales began in both states this week. Additionally, a bipartisan coalition of U.S.

Legislation 159

Legislation Decriminalization Access Therapy 159